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Introduction: Tuberculosis is a progressive and disabling infection predominantly seen in low-income and middle-
income countries. Immunocompromised patients are at a higher risk of contracting tuberculosis than the healthy
population. The presentation may also be atypical, leading to delay in diagnosis. We report the first case of tuberculous
cerebral vasculitis presenting with epilepsia partialis continua.
Case presentation: A 17-year-old adolescent boy of Sri Lankan Moor heritage was taking long-term
immunosuppressants for nephrotic syndrome. He presented to hospital with focal fits affecting his left arm. He later
developed choreiform movements of the same arm, progressing to epilepsia partialis continua and weakness. The
gradually evolving focal neurological signs and underlying immunosuppression raised the possibility of localized cerebral
infection or inflammation. Analysis of his cerebrospinal fluid showed lymphocytosis with normal cellular morphology.
Magnetic resonance imaging was suggestive of progressive vasculitic infarctions of the cerebral cortex and basal ganglia.
There was no evidence of active autoimmune or viral disease on hematological investigations, but molecular
amplification detected Mycobacterium tuberculosis in his cerebrospinal fluid. Although our patient had been established
on isoniazid preventive treatment for eight months before the episode, tuberculosis was nonetheless considered to be
the most likely cause of the cerebral vasculitis. He was treated with a trial of anti-tuberculosis treatment, including
streptomycin and adjunctive steroids, and made an uneventful recovery.
Conclusion: Clinicians should have a high index of suspicion for tuberculosis infection in patients with compromised
immunity and other risk factors. The pathophysiological mechanisms underpinning cerebral vasculitis and epilepsia
partialis continua are not completely understood. The efficacy of isoniazid prophylaxis in patients with immune
suppression warrants further study. We present a regimen that successfully treated tuberculous cerebral vasculitis.Introduction
Tuberculosis (TB) is a progressive and disabling infection
caused by Mycobacterium tuberculosis that is predomin-
antly seen in low-income and middle-income countries. It
primarily affects the lungs, but it can affect any other
organ system, including the central nervous system
(CNS). Tuberculous vasculitis is a chronic immune-
mediated vasculitis induced by M. tuberculosis that can
affect blood vessels of all sizes.
Retinal vasculitis commonly affects the retinal veins and
may cause retinal hemorrhage and neovascularization that
is sufficient to severely impair vision [1]. Tuberculous skin
manifestations due to vasculitis predominantly present as* Correspondence: vipbat7@yahoo.com
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aortitis is rare, but can lead to aneurysm formation and
rupture [3, 4]. Coronary arteritis due to tuberculous
vasculitis is extremely rare but can cause serious complica-
tions, such as myocardial infarction, arrhythmia, and
sudden death [5]. A rare case of tuberculous vasculitis and
nasal septal perforation has been reported in the literature,
illuminating a diagnostic dilemma caused by TB [6], in that
both TB and granulomatosis with polyangiitis (Wegener’s
granulomatosis) can destroy the nasal septum, giving rise to
a similar clinical picture. Tuberculous enteritis was found
in 87.5 % of cases diagnosed with abdominal TB in a study
conducted among Indian patients [7].
Cerebral TB has a spectrum of presentations, such
as meningitis, intracranial tuberculoma, and spinal tu-
berculous arachnoiditis, that is based on the tissues
affected and the underlying pathophysiological processAccess This article is distributed under the terms of the Creative Commons
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
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hyperintense left-sided subcortical lesions on magnetic
resonance imaging (MRI) consistent with infarction has
been reported [9]. Cerebral venous sinus thrombosis is re-
portedly another rare complication of TB meningitis [10].
Immunocompromised patients are at a higher risk of TB
infection than the healthy population. The presentation of
TB infection in an immunocompromised individual may
also be atypical, potentially delaying diagnosis [11]. The
diagnosis of tuberculous cerebral vasculitis cannot be made
by physical examination and imaging; laboratory and
microbiological confirmation is also essential. Nonetheless,
a high index of clinical suspicion is vital to guide the
physician to select the correct investigations. Because
of the complexity of its presentation and the difficulties that
might arise as a result of delayed diagnosis, it is important
to have a full understanding of the different presentations
of TB in high-risk populations. Here, we report what we be-
lieve to be the first case of tuberculous cerebral vasculitis
presenting as epilepsia partialis continua in a young man
with nephrotic syndrome.
Case presentation
A 17-year-old adolescent boy of Sri Lankan Moor heritage
who was taking long-term potent immunosuppressants was
admitted to the Emergency Medical Unit of our institution
with focal fits affecting his left arm, accompanied by
secondary generalization leading to status epilepticus. The
postictal period was complicated by periodic drowsiness.
He developed choreiform movements of the same arm on
the second day of admission, and the convulsions persisted
despite treatment with anticonvulsants. On the fifth day, he
developed weakness of his left arm without sensory impair-
ment. On the tenth day, he developed continuous abnormal
seizure-like movements of his left arm lasting for hours,
suggestive of epilepsia partialis continua. Our patient
remained afebrile throughout the illness, and he denied any
headache or photophobia. He was taking prednisolone
10mg and mycophenolate mofetil 500mg once daily, and
tacrolimus 5mg twice daily, as maintenance treatment for
steroid-resistant nephrotic syndrome. Our patient had been
taking 300mg isoniazid (INAH) preventive therapy (IPT)
for 8 months as a result of his potent immunosuppressant
regime and the high prevalence of TB among the urban
Moor population, which his nephrologist judged placed
him at high risk of TB infection.
Our patient’s hemodynamic parameters and random
blood sugar and electrolyte concentrations were within
normal limits. Results of a general examination were
normal except a Cushingoid appearance suggestive of
long-term corticosteroid use. He had no neck stiffness,
rash, or neurocutaneous manifestations. Examination of
his optic fundi was normal. On the first day of admission
he developed slurred speech. His arm weakness wassuggestive of an upper motor neuron-type paresis. Taken
together, his symptoms and signs were suggestive of a sub-
acute progressive pathology localized to the motor cortex
representing his left upper limb. The differential diagnoses
at this point were meningoencephalitis with abscess forma-
tion, cerebral lupus, or cerebral vascular occlusion.
Tacrolimus was stopped immediately on admission
because of the possibility of tacrolimus-induced CNS
toxicity. A complete blood count and liver function
test results were normal. His level of inflammatory
markers, erythrocyte sedimentation rate, and C-reactive
protein concentration were also normal. Serum anti-
nuclear antibody and double-stranded DNA tests were
negative, making cerebral lupus less likely. His previous
renal histology showed diffuse mesenchymal proliferation
with segmental sclerosis and patchy chronic tubulointer-
stitial changes in some glomeruli; however, his serum
creatinine concentration and a urine analysis were normal.
His serum calcium and magnesium concentrations were
within their normal ranges. A cerebrospinal fluid (CSF)
analysis showed normal protein and glucose concentra-
tions, with a scanty lymphocytic infiltrate with normal
cellular morphology. Electroencephalography confirmed
focal seizure activity with secondary generalization. Blood,
urine, and CSF cultures were negative for bacterial growth.
Chronic or atypical infection was suspected consider-
ing his immunosuppressed state. A tuberculin skin test
was measured as 12 mm, which was considered significant
in the context of his underlying immunosuppression. Acid-
fast bacilli were not isolated in his sputum, urine, or CSF.
Serum enzyme-linked immunosorbent assay (ELISA)
screening for human immunodeficiency virus (HIV) and
Venereal Disease Research Laboratory screening for syphilis
were both negative, while an ELISA of his CSF was negative
for Japanese encephalitis virus, herpes simplex virus 1 and
2, and cytomegalovirus immunoglobulin M.
Non-enhanced computed tomography (CT) of his brain
showed no abnormalities on the first day of admission. On
the third day of admission, T2-weighted MRI of his brain
revealed high intensity signals in his right hippocampal
gyrus, right putamen, and the head of the caudate nucleus,
suggestive of multiple infarctions (Fig. 1). Magnetic reson-
ance angiography and venography were normal, however,
excluding the possibility of macrovascular occlusion. MRI
was repeated 1 month later because of the progressive
nature of his symptoms and signs, and showed an increase
in the size of original lesions and the development of new
areas of involvement in the cerebral cortex with associated
vasogenic edema (Figs. 2 and 3). At the same time, a repeat
CT scan showed infarctions in the cortex but no basal
ganglia involvement (Fig. 4). Even though areas of infarc-
tion caused by a single event may have evolving
radiological features, the progressive clinical manifestations
we observed favored an on-going, persistent, and escalating
Fig. 1 Magnetic resonance image: transverse section of the brain
on the third day of admission. This section shows high T2 signals in
the right hippocampal gyrus, right putamen, and the head of the
caudate nucleus, suggestive of infarctions Fig. 3 Magnetic resonance image: coronal section of the brain 1 month
after the onset of illness. This section shows the involvement of the right
cerebral cortex and hippocampus due to multiple cerebral and basal
ganglia infarctions
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samples were sent for TB and fungal studies. Polymerase
chain reaction (PCR) testing for TB was positive in two in-
dependent samples performed at two different laboratories.
A quantitative PCR assay is reportedly an accurate and reli-
able means of quantitative detection of M. tuberculosis
DNA in CSF samples owing to the development of a new-
mutation plasmid as an internal control [12]. Another study
reported that the technique was less sensitive but more spe-
cific for the diagnosis of tuberculous meningitis in
individuals with HIV infection, individuals living in a TB-
endemic setting, particularly when a centrifuged CSF pelletFig. 2 Magnetic resonance image: transverse section of the brain 1
month after the onset of illness. This section shows new involvement of
the right cerebral cortex (right middle meningeal arterial territory) with
vasogenic edemais used (sensitivity 62 %, specificity 95 %) [13]. TB was con-
sidered the most likely cause for cerebral vasculitis in our
patient based on these findings. This case highlights the
effectiveness of TB PCR in the diagnosis of CNS TB,
obviating the need for brain biopsy.
In this case, MRI was supportive of our diagnosis
and was superior to CT for detecting CNS TB, which
concurs with the findings of previous studies [14, 15].
A hypercoagulable state is reported to increase the riskFig. 4 Computed tomography image: transverse section of the brain
1 month after the onset of illness. This section shows the infarctions
of the right cerebral cortex
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effectiveness of anticoagulants for the prevention of
cerebral infarctions caused by infective vasculitis has
not been properly evaluated. The diagnosis of TB in a
patient with underlying immunosuppression despite
latent anti-TB treatment (LTBT) raises the possibility
that IPT was ineffective in this clinical context. In a
previous study of IPT, only one patient from the group
treated with INAH was infected with TB during the study
period, compared with ten in the non-INAH group [17].
Nonetheless, resistance to INAH, and rifampicin when it is
used as an alternative, has been reported [18, 19]. Evidence
for the benefit of IPT as LTBT is lacking, and a multicenter
trial of IPT in an endemic area is warranted [20]. Because
TB is endemic in Sri Lanka, particularly in urban areas, it is
plausible that the strain of M. tuberculosis causing infection
in this case was resistant to INAH.
A variety of approaches to the treatment of CNS TB have
been taken, including combination therapy of an anti-TB
treatment (ATT) with an immunosuppressant such as oral
prednisolone, parenteral methylprednisolone pulse therapy,
or cyclophosphamide monotherapy; however, their efficacy
has not been properly established because of the lack of an
adequate cohort [11, 21]. In this case, we elected to
commence a 12-month course of ATT as per the World
Health Organization guidelines. This consisted of a 2-
month intensive phase of treatment with oral INAH 5
mg/kg/day, rifampicin 10mg/kg/day, and pyrazinamide
30mg/kg/day, and intramuscular streptomycin 20mg/kg/
day, followed by a 10-month maintenance phase of INAH
and rifampicin. Adjunctive methylprednisolone pulses
(1g/day for 3 days) were also given, followed by an oral
maintenance dose (1mg/kg once in the morning) for 1
month and then tapered off over another month. His anti-
convulsant therapy was sodium valproate 200mg three
times daily and clobazam 10mg twice daily. His nephrolo-
gist restarted immunosuppression for the underlying neph-
rotic syndrome; there was no recurrence of renal disease
on azathioprine 50mg once daily.
The combination of treatments put our patient at in-
creased risk of liver injury. We would have stopped therapy
if there had been any evidence of hepatotoxicity, and would
have started him on bridging therapy with non-hepatotoxic
ATT until the liver injury had resolved. We also monitored
his renal function to guide any dose adjustments. Regular
monitoring found that his serum creatinine concentration
and liver function test results remained normal throughout
his treatment regime. He responded well to treatment—the
convulsions resolved rapidly once ATT had started.
Surveillance imaging showed no further progression of
the cerebral lesions, further supporting the diagnosis
and choice of treatment strategy. The weakness in his
left arm persisted, however, suggesting that there had
nonetheless been a permanent brain injury. He wassubsequently able to achieve a partial improvement in
left arm power after intensive rehabilitation.
Conclusion
Our patient, who was taking immunosuppressants for
nephrotic syndrome, developed cerebral TB vasculitis
causing multiple cortical and basal ganglia infarctions
despite LTBT. The effectiveness of LTBT in immuno-
compromised patients requires further evaluation in
large-scale studies. We propose that our patient was in-
fected with an INAH-resistant M. tuberculosis species.
An ATT regime combined with steroids adequately
controlled the progression of CNS TB vasculitis in this
case. Further studies are needed to understand the
pathophysiologic basis for the association between
cerebral vasculitis and epilepsia partialis continua.
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